Emami Limited · NSE:EMAMILTD
Emami — Q2 FY2021 Earnings Presentation
21 slides from Emami's earnings presentation, Nov 5, 2020
Slide 1: Exchange filing cover letter
* cmami limited (;m<1m1??????????????D_a_t_e-:5-ili?N-ov_e_m_b_e_r,-2-0-20?? The Secretary The Secretary The National Exchange Stock of India Ltd. BSE Limited Exchange Plaza, No. C/1, G. Block Plot Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai - 400 051 Mumbai - 400
Slide 2: Q2 & H1FY21 Update
Q2 & H1FY21 Update 5th November 2020
Slide 3: Q2 & H1FY21 Revenues
Q2 & H1FY21 2 Revenues Q2FY21 H1FY21 Q2FY21 Business Wise Key Financials Growth Growth Sales Split Institutional • Domestic Business 13% -7% 3% • International Business 11% -4% Int'l Business 17% • Institutional Business -2% -21% Consolidated Net Sales 12% -7% Domestic 80% • Other Operating Income -
Slide 4: Q2FY21 Profitability (Consolidated)
Q2FY21 Profitability 3 (Consolidated) Q2FY21 Key Financials Margins Margin Growth Growth Revenues 11% - - Gross Profit 12% 70.3% + 60 bps EBIDTA 33% 35.0% + 570 bps PAT 23% 16.1% + 160 bps Cash Profit 31% 31.7% + 480 bps ▹ Margins increased due to stringent cost control measures and benign raw mater
Slide 5: Q2FY21 Domestic Portfolio Snapshot
Q2FY21 4 Domestic Portfolio Snapshot Portfolio Health & Hygiene Portfolio Winter Portfolio Other Brands Major Brands Hygiene Contribution* c. 47% + 44% + 14% c. 12% - 39% c. 41% & Growth *Q2FY21 Contribution to Domestic Business
Slide 6: Q2FY21 Domestic Performance
Q2FY21 5 Domestic Performance Highest +28% Domestic Business Growth Quarterly Sales excl. Winter Portfolio Achieved for Kesh King and in Q2FY21 ( c. 88% ) Pain Management Range Winter portfolio declined by 39% in Q2FY21 over a high base of 39% growth in Q2FY20
Slide 7: New Launches in Q2FY21 – Hygiene & Healthcare
New Launches in Q2FY21 – Hygiene & Healthcare 6 BoroPlus Antiseptic + Zandu Health Juices Zandu Immu Soft Chews Moisturizing Handwash Zandu Immuzan Tab Zandu Rhumasyl Maxx Giloy Ghana Vati Giloy Churna Zandu Amla Churna (Ethical) (Ethical) 8 New launches in Q2FY20
Slide 8: New Launches Performance
New Launches 7 Performance 20 New launches in H1FY21 40+ SKU’s launched in H1FY21 4% Contribution to Domestic Business (in Q2 & H1)
Slide 9: Q2FY21 Domestic Brandwise Performance
Q2FY21 Domestic 8 Brandwise Performance Key Brands Q2FY21 Growth H1FY21 Growth Healthcare Range 53% 40% Pain Management Range 31% 25% Navratna Range 14% -25% Kesh King Range 45% 2% BoroPlus Range -25% -16% Male Grooming Range -24% -51% 7 Oils in One 9% -16% H1FY21 Secondary Sales almost at par with
Slide 10: Launch of E-Commerce Portal
Launch of E-Commerce Portal 9 ▹ Launched own e-commerce portal- www.zanducare.com ▹ A brand store for Zandu Healthcare products ▹ Catering existing products as well as newly launched e-commerce specific products.
Slide 11: International Business Performance
International Business Performance 10 Sales grew by 11% in Q2 restricting the decline to 4% in H1FY21 OTHERS 11% Q2FY21 Sales performance- CIS 10% SAARC & SAARC grew by 22% IMD SEA MENAP grew by 12% H1FY21 39% Cluster Wise Contribution 7 Oils in One becomes the largest selling brand for ME
Slide 12: New Launches - International Business
New Launches - International Business 11 Creme 21 Range Turmeric Hand Hand Sanitizer Hand Sanitizer Hand Sanitizer Sanitizer Sanitizer Gel Spray Gel Tube wipes Gold Turmeric Range BoroPlus Range Anti-Bacterial Hand Wash & Soap Hand Sanitizer Hand Sanitizer Anti-Bacterial Soap
Slide 13: New TVC's
New TVC’s 12 New TVC for BoroPlus Hygiene range featuring Kesh King Shampoo Sachet launch TV Bollywood celebrity Juhi Chawla Campaign to promote trials New anti-stress campaign for New TVC for Zandu Ayurvedic Cough New TVC campaign for Zandu Navratna driving relevance in Syrup to continue relevance
Slide 14: Print & Digital Campaigns
Print & Digital No. Campaigns 13 Cee) ~ cocopws HAND SANITIZER FROM INDIA'S NO. ANTISEPTIC CREAM BRAND. Is YOUR f COMB AS b CLEAN/VAS ty MINE? q F i Safal kar karke kamar hogayi bend, Fir bhi ghar ka kaam hota nahi end
Slide 15: Q2FY21 Financial Analysis
Q2FY21 Financial Analysis 14 Cost of Goods Sold Staff Costs A&P Spends (as a % of Sales) (as a % of Sales) (₹ in Millions) - 60 bps - 70 bps - 120 bps 30.3% 1,049 1,081 11.4% 29.7% 10.7% Q2FY20 Q2FY21 Q2FY20 Q2FY21 Q2FY20 Q2FY21 Admin & Other Exp Other Income Interest Paid (as a % of Sales) (₹ in Mi
Slide 16: H1FY21 Financial Analysis
H1FY21 Financial Analysis 15 Cost of Goods Sold Staff Costs A&P Spends (as a % of Sales) (as a % of Sales) (₹ in Millions) - 180 bps + 120 bps - 410 bps 12.9% 33.0% 2,340 1,678 31.2% 11.7% H1FY20 H1FY21 H1FY20 H1FY21 H1FY20 H1FY21 Admin & Other Exp Other Income Interest Paid (as a % of Sales) (₹ in
Slide 17: Q2FY21 Summarized Financials
Q2FY21 Summarized Financials 16 ₹ in Millions Particulars Q2FY21 % Q2FY20 % Growth % FY20 % Net Sales 7,277.9 99.0% 6,486.2 98.3% 12.2% 26,106.4 98.3% Other Operating Income 70.3 1.0% 114.3 1.7% -38.5% 442.4 1.7% Revenue from Operations 7,348.2 100.0% 6,600.5 100.0% 11.3% 26,548.8 100.0% Materials C
Slide 18: H1FY21 Summarized Financials
H1FY21 Summarized Financials 17 ₹ in Millions Particulars H1FY21 % H1FY20 % Growth % FY20 % Net Sales 12,006.1 98.7% 12,880.1 98.4% -6.8% 26,106.4 98.3% Other Operating Income 155.5 1.3% 215.5 1.6% -27.8% 442.4 1.7% Revenue from Operations 12,161.6 100.0% 13,095.6 100.0% -7.1% 26,548.8 100.0% Materi
Slide 19: Balance Sheet
Balance Sheet ₹ in Millions As at As at As at As at Sl. ASSETS Sl. EQUITY AND LIABILITIES 18 30.09.2020 31.03.2020 30.09.2020 31.03.2020 1 Non -Current Assets Equity (a) Property, Plant and Equipment 7,405 7,685 (a) Equity Share capital 445 453 (b) Capital work-in-progress 55 69 (b) Other Equity 17,
Slide 20: Q2 Performance at a glance
Q2 Performance at a glance 19 ▹ Double digit volume growth in Domestic business. 28% growth excluding winter portfolio ▹ H1FY21 Secondary Sales almost at par with PY due to strong growth in Q2FY21 ▹ Growth across all channels –MT back to growth; E commerce tripled revenues ▹ Highest ever quarterly s
Slide 21: Thank you
Thank you